
Viridian Therapeutics Issues Inducement Equity Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
Viridian Therapeutics Announces Inducement Equity Grants for New Hires in Accordance with Nasdaq Rule 5635(c)(4) Viridian Therapeutics, Inc. (Nasdaq: VRDN), a clinical-stage biopharmaceutical company dedicated to advancing innovative therapies for patients with serious and rare diseases, today announced the approval…












